pbm glp-1 news March Healthcare Headlines: GLP-1s, PBMs, and The $233M Scam Virta Health Introduces Unified GLP-1

The origin of CAFs remains unclear, and some propose that they derive from the activation of resident fibroblast [98, 99], from recruited bone marrow progenitors [100], or the transdifferentiation from endothelial [101, 102] or epithelial to mesenchymal [103]

In these reactions, hydroxyl radicals act as potent oxidants, playing a role in re-establishing disrupted cellular energy dynamics

A Combined Approach: GLP-1 Agonists and Bariatric Surgery One exciting area of research and practice is the combination therapy involving both GLP-1 agonists and bariatric surgery, either preoperatively or postoperatively

Hepatology 76 (4), 951966

S., Anjum, N

Liu C, Lu XZ, Shen MZ, et al